Chinese fintech giant rumored to eye Venom acquisition as blockchain enters policy spotlight
05 Sept 2025 · 11:58 UTC · CoinCentral RSS Feed · Original source
Read original at CoinCentral RSS Feed →
Summary
Chinese media outlet Toutiao has reported that a major fintech company is in negotiations to acquire technology from the Abu Dhabi–based Venom Foundation. If confirmed, the deal would mark one of the largest cross-border blockchain technology transfers into the Chinese financial system and would align with Beijing’s call to modernize financial services using artificial intelligence.
Why it matters
This news could stimulate market interest, especially in assets related to advancements in blockchain technology and Chinese adoption. The potential for significant financial integration might also attract speculative trading. However, the speculation nature of the report means that many investors might remain hesitant, leading to volatility in both BTC and altcoin prices until more concrete information emerges.
Expected impact
The rumored negotiations for a potential acquisition of Venom by a major Chinese fintech firm could generate mixed reactions in the cryptocurrency market. While there is the possibility of increased interest and price appreciation in cryptocurrencies linked to blockchain advancements, uncertainty surrounding the deal's completion may lead to cautious sentiment among investors.